[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SI0921787T1 - ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS - Google Patents

ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS

Info

Publication number
SI0921787T1
SI0921787T1 SI9730615T SI9730615T SI0921787T1 SI 0921787 T1 SI0921787 T1 SI 0921787T1 SI 9730615 T SI9730615 T SI 9730615T SI 9730615 T SI9730615 T SI 9730615T SI 0921787 T1 SI0921787 T1 SI 0921787T1
Authority
SI
Slovenia
Prior art keywords
administration regimen
atpase inhibitors
atpase
inhibitors
regimen
Prior art date
Application number
SI9730615T
Other languages
Slovenian (sl)
Inventor
Christer Cederberg
George Sachs
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9602442A external-priority patent/SE9602442D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SI0921787T1 publication Critical patent/SI0921787T1/en

Links

SI9730615T 1996-06-20 1997-06-18 ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS SI0921787T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9602442A SE9602442D0 (en) 1996-06-20 1996-06-20 Administration of pharmaceuticals
EP97930933A EP0921787B1 (en) 1996-06-20 1997-06-18 ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS
PCT/SE1997/001098 WO1997048380A1 (en) 1996-06-20 1997-06-18 ADMINISTRATION REGIMEN OF H+, K+-ATPase INHIBITORS

Publications (1)

Publication Number Publication Date
SI0921787T1 true SI0921787T1 (en) 2004-04-30

Family

ID=32178726

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730615T SI0921787T1 (en) 1996-06-20 1997-06-18 ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS

Country Status (1)

Country Link
SI (1) SI0921787T1 (en)

Similar Documents

Publication Publication Date Title
HUP9901794A3 (en) Administration regimen of h+,k+-atpase inhibitors
GB2331015B (en) Therapeutic methods and compositions involving isoflavones
EP0875074A4 (en) Semiconductor devices, and methods for same
IL147803A0 (en) 28-epirapalogs
HUP9902455A3 (en) 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them
PL332432A1 (en) Oxadiazoles, method of obtaining them as well as their application as therapeutic agents
PL322579A1 (en) 2-methyl-thiene-benzodiazeoin prparation for oral administration
IL119994A0 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones their preparation and pharmaceutical compositions containing them
PL321201A1 (en) Derivatives of 4-hydroxypiepridine, method of obtaining them and therapeutic agents containing such derivatives
AU2879300A (en) Methods for anti-tumor therapy
PL314732A1 (en) S(+)-ethodolac preparations for oral administration
PL322526A1 (en) Azathiopyrin compositions for intracolic administration
HK1022432A1 (en) Administration of histamine for therapeutic purposes.
EP0656791A4 (en) Therapeutic compositions and methods using pqq.
IS5062A (en) Medicinal preparations containing N-sulfonylindoline derivatives
GB9700737D0 (en) Administration of drugs
AU4415797A (en) New pde iv inhibitors: "bis-compounds"
HK1042901A1 (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
AU4636396A (en) Antiglucocorticoid medicament
PL345068A1 (en) Novel compounds derived from α-d-xylose, preparation method and therapeutic use
EP1232159A4 (en) Beta-amyloid peptide inhibitors
SI0921787T1 (en) ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS
AU4003497A (en) Therapeutic methods and compositions involving isoflavones
AU2790095A (en) Thiopyridines for combating (helicobacter) bacteria
AU3423397A (en) Therapeutic methods and compositions for use therein